Introduction
Inflammasomes are cytosolic multimeric protein complexes formed in inflammatory cells in response to pathogenic infection and tissue injury (1) . Activated inflammasomes drive the processing of pro-inflammatory cytokine precursors such as prointerleukin-1β to its mature secreted form (IL-1β) and initiate inflammation (2) . The most commonly studied inflammasome is composed of the cytosolic pattern recognition receptor (PRR) NACHT, LRR and PYD domains-containing protein 3 (NLRP3). Aberrant activation of NLRP3 is now associated with the worsening of non-communicable diseases including atherosclerosis, Alzheimer's disease, type-II diabetes, arthritis and others (3), so a research priority has been to understand the mechanism of NLRP3 inflammasome activation.
Specific pathogen, or damage associated molecular patterns (PAMPs and DAMPs respectively), or stimuli that disrupt cellular homeostasis or integrity, induce the activation of NLRP3 (1, 4) . NLRP3 activation is represented by rapid conformational change of NLRP3 and its physical interaction with never in mitosis Arelated kinase 7 (NEK7) (5, 6) . Oligomerised NLRP3 then recruits the adaptor protein apoptosis-associated speck-like protein containing a caspase-recruitment domain (CARD) (ASC), which then assembles into large inflammasome specks upon which the CARD of ASC recruits pro-caspase-1 which undergoes a proximity dependent auto-activation to produce mature caspase-1 (7, 8) . Caspase-1 then cleaves substrate molecules such as pro-IL-1β which are released from the cell to promote inflammation (9) . The inflammasome specks released from pyroptotic cells can also further contribute to inflammatory responses (10, 11) .
NLRP3 inflammasome activation requires two sequential events for its activation in vitro. Toll-like receptor stimulation and NF-κB signalling induces expression of pro-IL-1β and NLRP3 (12) . Post-translational modifications involving NLRP3 phosphorylation and deubiquitination are crucial for subsequent inflammasome assembly (13) (14) (15) (16) . In addition to these priming and licensing events, K + efflux is now widely accepted as an essential second step in the activation of NLRP3 inflammasomes (17) . Recent studies also suggest a potential involvement of Cl -channels (18) (19) (20) , although exactly how Cl -channels contribute to inflammasome formation is unknown. Here we describe the regulation of NLRP3 inflammasomes by Cl -ion fluxes showing that Cl -efflux is the ASC oligomerising signal, but that a K + efflux dependent activation and interaction of NEK7 with NLRP3 is required for activation of caspase-1 and secretion of IL-1β.
Results

Effects of chloride on IL-1β secretion
To understand the effect of Cl -fluxes on inflammasome formation we performed ion substitution experiments and incubated LPS-primed primary mouse bone marrow derived macrophages (BMDMs) in isotonic solutions deficient in K + , Cl -or both, to drive efflux of K + or Cl -respectively. In the absence of additional inflammasome activators, K + free conditions induced a significant increase in levels of extracellular IL-1β ( Fig 1A) . IL-1β secretion was further enhanced in the combined absence of K + and Cl -( Fig 1A) . Cl -free conditions alone (with normal extracellular 5 mM K + ) had no effect on release of IL-1β ( Fig 1A) . The effects of K + , and K + and Cl -free conditions on IL-1β release were NLRP3 dependent as under the same conditions no IL-1β release was observed from primary BMDMs isolated from NLRP3 knockout (KO) mice (21) (Fig 1A) . IL-1β release under conditions of no extracellular K + or Cl -was also inhibited by broad spectrum Cl -channel blockers, suggesting that the effect of K + efflux was sensitive to Cl -channel inhibition ( Fig 1B) . The Cl -channel inhibitors used here inhibited Cl -channel activation in HeLa cells under hypotonic stress measured by I -quenching of halide-sensitive YFP H148Q/I152L (22) (Fig S1) . The recently described NLRP3 inhibitor NBC6 (23) also inhibited IL-1β release under conditions of no K + and Cl - (Fig 1B) . The Cl -channel inhibitors used here were previously reported to specifically inhibit the NLRP3 inflammasome (18) , and do not inhibit production of TNFα as reported previously (19) and as shown in Fig S2. A temporal analysis of IL-1β release under K + free, or K + and Cl -free conditions up to 3 hours revealed that IL-1β release was not only enhanced, but also released more rapidly under conditions of K + and Cl -free (Fig 1C) . Cl -free solutions in the presence of K + did not induce any IL-1β release, even with up to 3 hours incubation ( Fig 1C) . A similar pattern to IL-1β release was observed for cell death in the ion substitution experiments with significant cell death in the K + free, and K + and Cl -free conditions (Fig 1D) . The cell death was also NLRP3 dependent suggesting that it could be pyroptotic (Fig 1D) . Cl -channel inhibitors also inhibited LPS and nigericin induced IL-1β release from immortalized (i) mouse BMDMs (Fig 1Ei) without affecting nigericin induced K + efflux from these cells as measured by ICP-MS (Fig 1Eii) . Conditions of K + free, and K + and Cl -free also induced IL-1β release from LPS-primed human THP1 monocytes (Fig S3A) . Cl -channel blockers also prevented K + and Cl -free solution induced IL-1β release from LPS-primed THP1 monocytes (Fig S3B) . These data suggest that Cl -channel activation is essential for NLRP3 inflammasome activation, consistent with previous observations (18) (19) (20) , and that the Cl -channel dependent effect can be blocked without affecting K + efflux.
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Chloride dependence of ASC speck formation
Using iBMDMs stably expressing ASC-mCherry (18) we studied the effects of Cl -channel activation on inflammasome speck formation. Incubation of LPS-primed ASC-mCherry iBMDMs in both Cl -free, and K + and Cl -free solutions induced formation of ASC specks (Fig 2A) . Thus, Cl -free conditions are sufficient to induce the formation of ASC inflammasome specks without inducing the activation of caspase-1, whereas K + free alone conditions induced IL-1β release without inducing significant ASC speck formation. We then analysed ASC speck formation over time in LPS-primed ASC-mCherry expressing iBMDMs using the same solutions, but with the addition of solutions composed of 150 mM KCl, or 150 mM KGluconate, concentrations of K + far in excess of those required to inhibit NLRP3 inflammasome activation (17) . In this experiment we observed significant ASC speck formation in the absence of Cl -, and in the absence of K + and Cl -, as expected ( Fig 2B) . Cells incubated in 150 mM KCl did not form many specks, although incubation in 150 mM KGluconate did induce a modest but significant formation of ASC specks (Fig 2B) . These data reveal speck formation in the presence of inflammasome inhibiting levels of K + , but in the absence of any Cl -. The NLRP3 dependence of Cl -free solution inducing ASC speck formation was confirmed using wild type (WT) and NLRP3 knockout (KO) THP1 macrophages and staining for ASC specks using immunocytochemistry after incubation in the Cl -free, and K + and Cl -free solutions described. Here we observed that ASC speck formation under Cl -free conditions was completely NLRP3 dependent ( Fig 2C) . We then repeated the experiments on IL-1β release and ASC speck formation with the Cl -and K + free buffers but added i) 10 mM HEPES (pH 7.3), ii) 5 mM glucose, iii) 1 mM CaCl 2 , or iv) HEPES, glucose, and CaCl 2 ( Fig S4) . These experiments were conducted in primary BMDMs (for IL-1β release) and iBMDMs expressing ASC-mCherry (for ASC speck formation). Under all these new conditions Cl -free buffers still failed to cause IL-1β release, but did cause ASC speck formation (Fig S4) , fully supporting the data presented in Fig 2. Using WT and NLRP3 KO THP-1 macrophages we crosslinked ASC using disuccinimidyl suberate (DSS) and detected ASC oligomerisation using immunoblotting (24) . In Cl -free conditions in LPS-primed THP-1 cells there was ASC oligomerisation and this was absent in NLRP3 KO cells, further confirming the NLRP3 dependence of Cl -channel dependent ASC oligomerisation (Fig 3A) . Given caspase-1 or mature IL-1β produced - Fig 1) we investigated whether caspase-1 was recruited to these inactive ASC specks.
Recent research has shown that biotin-VAD-fmk (bVAD-fmk) is a useful probe for activated caspases (25 excess bVAD were removed, and active caspase-1 bound to bVAD/streptavidin beads was pulled down for immunoblotting.
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conditions we also blotted for ASC, confirming an association of the activated caspase-1 to ASC (Fig 3B) . When we analysed 
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incubations in buffers that were K + free (Fig 3B) . In control or only Cl -free conditions there was no caspase-1 and ASC pull down (Fig 3B) . These data suggest that under conditions of Cl -free driving formation of inactive ASC specks there is no caspase-1 activation because it is not recruited.
We then looked at ASC speck formation in the ASC-mCherry iBMDMs in Cl -free conditions in the absence and presence of the NLRP3 inflammasome inhibitor MCC950 (26) . MCC950 effectively inhibited ASC speck formation in Cl -free, K + and Cl -free and in high K + and Cl -free (150 mM KGluconate) containing solutions (Fig 3C) . ASC speck formation induced by Cl -free, and K + and Cl -free conditions was also inhibited by Cl -channel inhibitors (Fig 3D) . Incubation of primary mouse BMDMs with the respective solutions revealed that only K + free solutions induced K + efflux, and that the Cl -free solution (which contains K + ) did not, as measured by ICP-MS (Fig 3E) . Using ion chromatography we were also able to determine that Cl -loss occurred specifically from cells incubated with the Cl -free buffers (Fig 3F) . Further, pharmacologically induced Cl -efflux in LPSprimed ASC-mCherry iBMDMs using Eact, a selective agonist of the calcium activated chloride channel ANO1 (27) , dose dependently induced ASC speck formation (Fig S5A) . Formation of Eact-dependent ASC specks was blocked using the selective ANO1 antagonist Ani9 (28), the NLRP3 inhibitor MCC950, and the Cl -channel inhibitor NPPB (Fig S5B) . Similar to the Cl -free conditions, Eact did not induce IL-1β processing and release ( Fig  S5C) . The ANO1 inhibitor Ani9 did not inhibit nigericin induced IL-1β release (Fig S5D) , or cell death (Fig S5E) in iBMDM cells. These data suggest that Cl -channel activation and Cl -efflux are essential for ASC speck formation and that Cl -efflux can occur independently of K + efflux. In the absence of K + efflux, the ASC specks do not activate caspase-1.
We next incubated LPS-primed primary BMDMs in K + and Cl -free conditions to induce NLRP3 inflammasome activation, caspase-1 activation and IL-1β release and added back up to 5 mM extracellular K + . Addition of K + dose dependently inhibited the activation of caspase-1 and IL-1β secretion (Fig 4A) . Thus we are observing 2 events combining to facilitate the activation of caspase-1 and IL-1β secretion; a Cl -efflux dependent formation of an ASC speck, and a K + efflux dependent activation of caspase-1. We tested whether specks formed under Cl -free conditions could 'prime' or enhance inflammasome dependent responses. LPS-primed BMDMs were stimulated in Cl -free solution to form inactive ASC specks as above, and were then stimulated with nigericin to induce K + efflux and IL-1β release and were compared to cells incubated under normal K + and Cl -conditions (Fig 4B) . There was an accelerated and enhanced activation of caspase-1 and release of IL-1β in BMDMs pre-incubated in Cl -free solution within the first 15 min and subsequent time points, suggesting that the specks formed under Cl -free conditions are competent for subsequent inflammasome activation and IL-1β processing. Currently the formation of the inflammasome speck is considered to be a terminal event dependent upon prion like properties of the ASC-molecule (10, 11) . The formation of the ASC speck under Cl -free conditions did not result in caspase-1 activation and there was no pyroptotic cell death (Fig 1) and so we were able to test whether ASC oligomerisation is dynamically regulated by extracellular Cl -. LPS-primed THP1 cells were incubated in Cl -free solution before ASC oligomerisation was measured by DSS cross-linking and immunoblotting as described above. Incubation of the cells in Cl -free (but K + containing) solution resulted in ASC oligomerisation as indicated by high molecular weight ASC bands in the Triton-X100 insoluble fraction (Fig 4C) . Reintroducing Cl -containing solution back to the cells at this point caused a reversal of ASC oligomerisation when measured 30 minutes later which was sustained for the duration of the experiment (Fig 4C) . We then used ASC-mCherry iBMDMs to determine if Cl -free dependent ASC speck formation was reversible. LPS-primed ASC-mCherry iBMDM cells were incubated in Cl -free solution for 120 min and numbers of cells with ASC specks were quantified (Fig 4D) . In one experimental group extracellular Cl -levels were returned to normal (reperfused), whilst the other group remained extracellular Cl -free, and specks continued to be monitored. Here we observed that Cl -free dependent speck formation was also dynamic and reversible, albeit over a slower time course than oligomerisation measured above ( Fig  4D) . The kinetics of oligomerisation measured by immuno-blot, and of speck formation measured by microscopy are different supporting the concept that oligomerisation to soluble oligomers precedes the formation of more stable specks. These data suggest that ASC oligomerisation and speck formation are dynamic and reversible processes regulated by Cl -.
Effects of chloride on NLRP3 oligomerisation
Although Cl -free ASC speck formation was shown to be NLRP3 dependent (Figs 2-3) , the fact that the specks were not recruiting active caspase-1 suggested that NLRP3 may not exist in an oligomerised active state under these conditions. To test the activation state of NLRP3 we assessed its oligomerisation under conditions of Cl -, K + , or K + and Cl -free. Using native gel electrophoresis as described previously (5, 29) and immunoblotting for NLRP3, we observed an increased shift in molecular weight of NLRP3 under conditions of K + free, or K + and Cl -free, but not of Cl -free alone (Fig 5A) . These data suggest that the formation of high molecular weight complexes containing oligomeric NLRP3 requires K + efflux (Fig 5A) . We subsequently performed SDS-PAGE under denaturing conditions with these samples to examine processing of caspase-1. Caspase-1 cleavage occurred exclusively in conditions where NLRP3 oligomerisation was present, suggesting NLRP3 oligomerisation is necessary for caspase-1 cleavage (Fig 5A) . To confirm that NLRP3 oligomerisation was different upon selective K + and Cl -efflux, we performed BRET experiments using the NLRP3 BRET sensor as described previously (30) . HEK293T cells expressing Luc Ct-NALP3-Nt YFP were incubated with different solutions and NLRP3 conformation was monitored over time. We found that both K + free and Cl -free solutions were able to induce modest but different changes in the BRET signal (Fig S6A) . Microscopy of the YFP label on the NLRP3 construct revealed that Cl -efflux did not induce NLRP3 speck formation, but when cells were incubated in K + free solutions NLRP3 specks were observed (Fig S6B) . These data are consistent with the data presented in Fig 5A suggesting that K + efflux is necessary for NLRP3 oligomerisation. The association between NEK7 and NLRP3 is reported to be dependent upon K + efflux (5). Thus we performed coimmunoprecipitations of NEK7 and NLRP3 under Cl -free, and K + and Cl -free conditions. After 30 minutes in K + and Cl -free solution we could detect a clear interaction between NEK7 and NLRP3 (Fig 5B) . NLRP3-NEK7 interaction was also apparent in K + free (Cl -containing) conditions at 60 minutes, at which time the interaction was even more apparent in the K + and Cl -free solution (Fig 5B) . To determine if NEK7 was present in the oligomerised NLRP3 complexes formed under K + and Cl -free conditions, we first separated samples in one dimension by native gel electrophoresis and then in a second dimension by SDS-PAGE. Immunoblotting revealed that under conditions of K + and Cl -free, but not Cl -free alone, induced the formation of a high molecular weight complex including NEK7 and NLRP3 (Fig 5C) . These data suggest that the K + sensor which is required for NLRP3 oligomerisation and a functional caspase-1 activating inflammasome is NEK7. Thus, while Cl -free conditions drive NLRP3-dependent ASC oligomerisation and speck formation, in the absence of NEK7 binding and NLRP3 oligomerisation, these specks remain inactive and do not recruit active caspase-1.
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Effects of chloride on the alternative NLRP3 inflammasome in human PBMCs
It has been known for some time that LPS can directly induce the release of IL-1β from freshly isolated human monocytes without the need for a secondary stimulus (31) . More recent research has characterised this as the 'alternative' NLRP3 inflammasome which is less dependent on K + efflux and does not rely on ASC oligomerisation (32) . We therefore tested whether Cl -free conditions could influence IL-1β production by the alternative NLRP3 inflammasome in PBMCs freshly isolated from healthy donors. When the cells were stimulated with LPS in RPMI media there was no ASC oligomerisation, though there was caspase-1 activation and mature IL-1β production (Fig 6A) . We repeated this experiment in Cl -containing and Cl -free PBS (supplemented with 10mM glucose, 1% FBS, and 2 mM L-Glutamine) and found that under these conditions there was some ASC oligomerisation in response to LPS in PBS (Fig 6A) . Intriguingly, Cl -free PBS alone induced ASC oligomerisation, caspase-1 cleavage, and IL-1β processing, which was markedly enhanced by the addition of LPS (Fig 6A) . The formation of these Cl -free dependent ASC oligomers was reduced by MCC950 confirming NLRP3 dependence (Fig 6B) . The Cl -channel inhibitor NPPB also inhibited Cl -free and LPS-induced ASC oligomerisation in human PBMCs (Fig 6C) . We then repeated the experiment in PBMCs in PBS and Cl -free PBS plus and minus LPS and this time, nigericin. This experiment showed that nigericin induced ASC oligomerisation and caspase-1 activation in LPS treated PBMCs comparable to Cl -free conditions (Fig 6D) . These data suggest that Cl -free conditions in PBMCs do not activate the alternative pathway, but rather, activate the canonical pathway. Thus, the alternative NLRP3 inflammasome forms independently of ASC oligomerization, and thus independently of the Cl -dependent effect reported here.
Discussion
These data reveal a new mechanism regulating the assembly of the NLRP3 inflammasome and allow us to propose a new model that opens future studies on an additional priming and regulatory step that may further amplify inflammatory responses. Here we show that there is a Cl -channel dependent step whereby NLRP3 nucleates the oligomerisation of an ASC speck. This complex can remain inactive, however, K + efflux permits NEK7 to bind to NLRP3 causing its oligomerisation and activation of the complex. Altered ion balance and transport is a well-established contributor to inflammatory disease (33), and we recently reported that the fenamate NSAIDs inhibit inflammation by virtue of their ability to inhibit Cl -channels on macrophages (18) . We can thus envisage situations where cells are primed to contain fully formed inflammasome specks which will allow a heightened and rapid inflammatory response to subsequent inflammatory situations. It is therefore possible to consider cellular regulation of Cl -as a therapeutic target in inflammatory disease.
Following our publication describing the fenamate NSAIDs as NLRP3 inhibitors through their ability to inhibit Cl -channels (18) , several subsequent studies have further reported the importance of Cl -channel activation, and they point to the importance of chloride intracellular channel (CLIC) proteins (19, 20) . Interestingly there is evidence to suggest that the NLRP3 inhibitor MCC950 could be a CLIC inhibitor as a related analogue was shown to bind CLIC1 (19, 34) , and more recently MCC950 was reported to inhibit Cl -flux from cells (35), though we did not observe this after VRAC activation ( Supplementary Fig 1) . LPS activation of macrophages drives CLICs to the plasma membrane where they can facilitate Cl -flux after NLRP3 inflammasome activating stimuli, and knockdown of CLICs reduces NLRP3-inflammasome-dependent release of IL-1β (19, 20) . Furthermore, previous research examining the effects of Cl -on P2X7-dependent IL-1β release attributed enhanced responses in Cl -free conditions to allosteric effects on the P2X7 receptor, and the potential of increased intracellular Cl -to negatively regulate the activation of caspase-1 (36) . These studies, our previous research (18) , and several other studies from the literature showing that Cl -channel inhibitors block the release of IL-1β (37-39), strongly support an important role for Cl -efflux in inflammasome assembly and IL-1β secretion.
In this study, we have dissociated Cl -dependent effects from those caused by K + efflux and report that NLRP3 dependent ASC oligomerisation is Cl -efflux dependent, dynamic and reversible. ASC speck formation is generally considered an essential and sufficient event for NLRP3-dependent inflammasome activation. We report here formation of ASC specks without the downstream activation of caspase-1 and release of IL-1β. We show that Cl -efflux dependent pre-formed inflammasome specks may represent a further phase of priming to accelerate and amplify inflammatory responses, potentially in a positive feedback loop as recently described for the amplification of AIM2 oligomerisation (40) . When there is a concomitant efflux of K + we report that NEK7 binds to NLRP3 leading to caspase-1 recruitment and the formation of an active inflammasome (Fig 5) . Cl -efflux dependent ASC specks can also undergo a rapid disassembly following restoration of intracellular Cl -levels providing new insight in to the dynamic nature of these complexes (Fig 4) . These insights now open the door for studies of inflammasome assembly in the absence of pyroptotic cell death and reveal further levels of regulation for the NLRP3 inflammasome. Further understanding of the effects of Cl -will reveal and refine future and current therapeutic targets respectively. Given that there are Cl -channel inhibiting drugs available and that the well characterised inhibitor MCC950 may be a CLIC inhibitor suggests that there is considerable therapeutic potential in understanding the contribution of Cl -channels to inflammation. Our data also highlight the importance of understanding the regulation of inflammasome complexes when considering therapeutic strategies. In conditions where alternative NLRP3 inflammasomes contribute to disease Cl -channel inhibition is unlikely to be a viable therapeutic strategy (Fig 6) . Rather, diseases dependent upon ASC speck formation, such as Alzheimer's disease (41), may be more likely to respond specifically to therapies targeting formation of the ASC speck. Indeed in rodent models of Alzheimer's disease Cl -channel inhibitors are protective (18) . Further understanding of inflammasome activation in disease models will therefore enable a more refined approach to inflammasome targeting.
Methods
Antibodies and Reagents
Details are in the supplementary information. Cell culture Primary bone marrow derived macrophages (BMDMs) were prepared by flushing femurs of male and female wild-type (WT) C57BL/6 mice (Envigo) or NLRP3 KO mice. Red blood cells were lysed and BMDMs were generated by culturing the resulting marrow cells in 70% DMEM (containing 10% (v/v) FBS, 100 U ml -1 penicillin, 100 μg ml -1 streptomycin) supplemented with 30% L929 mouse fibroblast-conditioned media for 7-10 days. Before experiments, BMDMs were seeded overnight at a density of 1 x 10 6 ml -1 . Human WT and NLRP3 KO THP-1 cells were cultured in RPMI-1640 medium supplemented with 10% (v/v) FBS, 100 U ml -1 penicillin and 100 μg ml -1 streptomycin, 20 mM L-Glutamine and 55 μM 2-mercaptoethanol. Before experiments, THP-1 cells were seeded overnight at a density of 1 x 10 6 ml -1 in media supplemented with 500 nM phorbol 12-myristate 13-acetate (PMA). Immortalised BMDMs (iBMDMs) and iBMDMs stably expressing ASC-mCherry (18) were cultured in DMEM supplemented with 10% (v/v) FBS, 100 U ml -1 penicillin and 100 μg . Briefly, PBMCs were separated from leukocyte cones using Ficoll reagent (ThermoFisher) at 400 x g for 40 min at room temperature. The layer containing PBMCs were gently isolated using a Pasteur pipette and washed at least 3 times in sterile PBS supplemented with 1% FBS and 2 mM EDTA to remove debris and platelets. PBMCs were counted and seeded out in in RPMI-1640 medium supplemented with 1% (v/v) FBS and 2 mM L-Glutamine in 12-well plates at 5 x 10 -6 density per well.
PBMCs were then stimulated with or without 1 µg ml -1 LPS for 20 h. For the buffer stimulations, PBMCs were directly resuspended in PBS or Cl -free PBS supplemented with 10 mM D-glucose, 1% FBS and 2 mM L-Glutamine, and stimulated with or without 1 µg ml -1 LPS for 20 h. Both cell supernatants and lysates were collected for immunoblotting.
Inflammasome activation assays Primary BMDMs and THP-1 cells were primed with 1 μg ml -1 LPS (from Escherichia coli O26:B6, Sigma) for 4 h. iBMDMs were primed with 1 μg ml -1 LPS for 2 h. After priming, cells were reperfused with the indicated isotonic salt solution: control (145 mM NaCl/5 mM KCl), Cl -free (145 mM NaGluconate/5 mM KGluconate), K + free (150 mM NaCl), or K + and Cl -free (150 mM NaGluconate). When specified, solutions were supplemented with CaCl 2 (2 mM), glucose (10 mM) or HEPES (10 mM, pH 7.3). When used, chloride channel and NLRP3 inhibitors were added to the solutions just prior to reperfusion. For experiments where NLRP3 agonists were used, cells were incubated in either serum free DMEM (primary BMDMs, iBMDMs) or RPMI-1640 (THP-1) media and stimulated with nigericin (10 μM, 1 h) or ATP (5 mM, 1h). When used, chloride channel and NLRP3 inhibitors were pretreated for 15 min prior to inflammasome stimulation. Supernatants were collected and cells were lysed in RIPA buffer (150 mM NaCl, 1% (v/v) NP-40, 0.5% (w/v) sodium deoxycholate, 0.1% (w/v) sodium dodecyl sulphate, 50 mM Tris, pH 8), supplemented with a protease inhibitor cocktail.
IL-1β release was determined in supernatants by ELISA (DuoSet, R&D systems) according to the manufacturer's instructions. IL-1β and caspase-1 processing was determined by immunoblotting. When necessary, both cell supernatant and lysates were collected and precipitated in deoxycholate containing 20% trichloroacetic acid (20% TCA) and washed 3 times with 100% acetone, before concentrated in 1X Laemmli buffer. All supernatants or cell lysates were separated by Tris-glycine SDS-PAGE and then transferred onto nitrocellulose or PVDF membranes at 25 V using a semi-dry Trans-Blot Turbo system (Biorad). Membranes were blocked in 5% (w/v) milk in PBS, 1% (v/v) Tween 20 (PBST) before incubated with indicated primary antibodies at 4°C overnight. Membranes were then labelled with HRP-tagged secondary antibodies and visualised with Amersham ECL detection reagent (GE healthcare). Immunoblot images were captured digitally using a G:Box Chemi XX6 (Syngene) or C-digit scanner (Li-Cor). Cell supernatants were also assayed for lactate dehydrogenase (LDH) release using CytoTox 96® non-radioactive cytotoxicity assay (Promega) according to manufacturer's instructions.
Intracellular K + and Cl -determination Intracellular K + measurements were performed by inductively coupled plasma-mass spectrometry (ICP-MS) using a 7700x Inductively Coupled Plasma-Mass Spectrometer (Aligent) as previously described (42) at the Centre for Advanced Discovery and Experimental Therapeutics (CADET), University of Manchester. LPS-primed iBMDMs (1 µg ml -1 , 2 h) were preincubated with the chloride channel inhibitors DCPIB (10 µM) or NPPB (100 µM) for 15 min before stimulation with nigericin (10 µM) for 30 min. LPS-primed primary BMDMs (1 µg ml -1 , 4 hours) were pre-treated with the pan-caspase inhibitor Z-VAD-FMK (50 µM), to prevent pyroptosis, before incubation in control (145 mM NaCl/5 mM KCl), Cl -free (145 mM NaGluconate/5 mM KGluconate), K + free (150 mM NaCl), or K + and Cl -free (150 mM NaGluconate) salt solutions for 2 h. Cells were scraped on ice and washed three times in K + -free PBS (130 mM NaCl, 7 mM Na 2 HPO 4 , 3 mM NaH 2 PO 4 , pH 7.2). Cell pellets were frozen at -20°C until digested in concentrated nitric acid and processed for ICP-MS. Intracellular K + measurements were corrected against cell pellet weight prior to digestion.
Intracellular Cl -was determined by ion-exchange chromatography. 2 x 10 6 LPS primed (1 µg ml -1 , 4 h) NLRP3 KO BMDMs were incubated in control (145 mM NaCl/5 mM KCl), Cl -free (145 mM NaGluconate/5 mM KGluconate), K + free (150 mM NaCl), or K + and Cl -free (150 mM NaGluconate) solutions for 2 h. Cells were placed on ice, washed once with a Cl -free solution and scraped. Cell pellets were lysed in 1 ml ddH 2 O, vortexed and subjected to two freeze-thaw cycles. Cellular material was removed before running the samples by passing the lysate through a 0.22 µm filter. Ion chromatography was performed on a ICS5000 Dual Channel Ion Chromatograph (Dionex) using a AG18 guard column and a AS18 analytical column (Dionex). Experimental Cl -concentrations were determined using calibration standards for chloride (Spex Certiprep). Chlorate was added to each sample as an internal standard.
H148Q/I152L YFP quenching assay A cell based assay for measuring chloride channel activity was performed as previously described with pcDNA3.1 EYFP H148Q/I152L (22), a gift from Peter Haggie (Addgene plasmid # 25872). Further details are in the supplementary information.
ASC speck imaging Real-time ASC speck assays were performed using iBMDMs stably expressing ASC-mCherry (ASC-mCherry iBMDMs). 7.5 x 10 4 iBMDM ASCmCherry were seeded overnight into 96 well plates and subsequently primed for 2 h with 1 μg ml -1 LPS. To prevent pyroptosis and detachment during the experiment, iBMDMs were pre-treated with the pan-caspase inhibitor Z-VAD-FMK (50 µM) for 30 min prior to microscopy. After priming, cells were reperfused with the indicated isotonic salt solution: control (145 mM NaCl/5 mM KCl), Cl -free (145 mM NaGluconate/5 mM KGluconate), K + free (150 mM NaCl), K + and Cl -free (150 mM NaGluconate), high K + and normal Cl -(150 mM KCl), or high K + and Cl -free (150 mM KGluconate). When appropriate, cells were treated with either: a vehicle control, DCPIB (10 µM), flufenamic acid (100 µM), NPPB (100 µM), or the NLRP3 inflammasome inhibitor MCC950 (10 µM). Images were captured at using a 20x/0.61 S Plan Fluor objective at 15 min intervals and quantified using an IncuCyte ZOOM® System (Essen Bioscience). Comparison of ASC speck formation between treatments was analysed after stimulation for 3 h. All experiments involving the ANO1 agonist Eact were performed in OptiMEM.
WT and NLRP3 KO THP-1 cells were seeded overnight onto sterilised 10 mm coverslips in 24-well plates at a density of 1 x 10 6 ml -1 cells, supplemented with PMA (500 nM). THP-1 macrophages were primed with LPS (1 µg ml -1 , 4 h) before reperfusion with the indicated isotonic salt solution: control (145 mM NaCl/5 mM KCl), Cl -free (145 mM NaGluconate/5 mM KGluconate), K + free (150 mM NaCl), or K + and Cl -free (150 mM NaGluconate) and incubated for 3 h. All solutions contained Z-VAD-FMK (50 µM) to prevent pyroptosis and therefore loss of ASC specks. Cells were washed with cold PBS and then fixed with 4% (w/v) PFA for 20 min. Fixed cells were blocked and permeabilised with 1% (w/v) BSA, 0.1% (v/v) Triton X100, 0.05% (v/v) Tween 20 in PBS. Anti-ASC antibodies were incubated in 1% (w/v) BSA, 0.3% (v/v) Triton X in PBS overnight at 4°C. Coverslips were then washed 3 times with PBS before incubation with anti-rabbit AlexaFluor488 secondary antibodies (Thermo Fisher) for 1 h at RT. After a further 3 washes with PBS, cells were stained with 1 μg ml -1 DAPI. Samples were washed 3 times before being mounted in Prolong Diamond® (Thermo Fisher). For experiments testing reversal of ASC specks, ASC-mCherry iBMDMs were seeded overnight onto sterilised 10 mm coverslips at density of 0.75 x 10 6 ml -1 . ASC-mCherry iBMDMs were primed with LPS (1 µg ml -1 , 2 h) and stimulated as indicated in the presence of Z-VAD-FMK (50 μM). ASC-mCherry iBMDMs were washed with cold PBS and fixed with 4% (w/v) PFA for 20 min. Fixed cells were stained with 1 μg ml -1 DAPI, washed a further 3 times in PBS before being mounted in Prolong Diamond®. Images were captured using a 20x objective on a Zeiss Axioimager D2 upright microscope and subsequently processed using imageJ software.
ASC oligomerisation assay 1 x 10 6 WT and NLRP3 KO THP-1 cells were seeded into 12-well plates and incubated overnight with PMA (500 nM). Following LPS-priming (1 µg ml -1 , 4 h), cells were incubated in the indicated isotonic salt solution: control (145 mM NaCl/5 mM KCl), Cl -free (145 mM NaGluconate/5 mM KGluconate), K + free (150 mM NaCl), or K + and Cl -free (150 mM NaGluconate), for 2 h. Cells were directly lysed in the well by the addition of 1% (v/v) Triton-X100 and protease inhibitor cocktail. Cell lysates were separated into Triton-X100 soluble fraction and insoluble fraction using differential centrifugation at 6800xg for 20 min at 4°C. The soluble fraction of cell lysates was subsequently used for immunoblotting whereas the Triton-X100 insoluble pellets were chemically crosslinked with 2 mM DSS (Thermo Fisher) for 30 min at RT. Crosslinked pellets were further spun down at 6800xg for 20 min and eluted in Laemmli buffer for SDS-PAGE.
Active caspase-1 pulldown For active caspase-1 pulldown, a cell-permeable pan-caspase activity probe biotin-VAD-fmk (bVAD) (Santa Cruz: sc-311290) was used as previously described (25) . Briefly, 1.5 x 10 6 WT BMDMs were seeded into 12 well plates and incubated overnight. 5 µM bVAD was pre-mixed in stimulating conditions before re-perfused onto LPS-primed (1 µg ml -1 , 4 h) BMDMs for 1 h. Cell supernatant containing excess bVAD was removed. For caspase-1 pulldown, cells were lysed overnight in 1% Triton-X100 lysis buffer supplemented with EDTA-free protease inhibitor cocktail and 1 mM PMSF. Cell lysates were then incubated in magnetic Streptavidin T1 dynabeads (ThermoFisher) for 1 h. The proteins bound to streptavidin were washed 3 times using 1% Triton-X100 lysis buffer before re-suspended in 1x Laemmli buffer and boiled prior to immunoblotting.
Blue native PAGE and 2D PAGE For 1D Blue Native-PAGE (BN-PAGE), 2 x 10 6 primary WT and NLRP3 KO BMDMs were seeded overnight into 6 well plates. LPS primed BMDMs (1 µg ml -1 , 4 h) were incubated in a control (145 mM NaCl/5 mM KCl), Cl -free (145 mM NaGluconate/5 mM KGluconate), K + free (150 mM NaCl), or K + and Cl -free (150 mM NaGluconate) solution for 30 or 60 min. Alternatively, BMDMs were incubated in serum free DMEM and stimulated with ATP (5 mM, 30 or 60 min). For 2D-PAGE, Z-VAD-FMK (50 µM) was added simultaneously to prevent loss of protein. Cells were lysed in a native lysis buffer (20 mM Bis-tris, 500 mM 6-aminocaproic acid, 20 mM NaCl, 10% (v/v) glycerol, 0.25% (w/v) digitonin, 0.25% (v/v) Triton-X100, 0.5 mM Na 3 VO 4 , 0.5 mM NaF, 1 mM PMSF, EDTA-free protease inhibitor cocktail, pH 7.0) for 30 min at 4°C. Insoluble debris was pelleted by centrifugation at 20000xg for 30 min at 4°C. Soluble lysates were separated by isoelectric focusing using Coomassie brilliant blue G-250 (Fluka) on 3-12% NativePAGE BisTris gels (Thermo Fisher) as described previously (5, 43) . Proteins were then denatured by incubating the gel in 10% SDS for 10 min before semi-dry transfer and immunoblotting with indicated antibodies. For second dimension PAGE, 6.5 cm of BN-PAGE gel slices was 1225  1226  1227  1228  1229  1230  1231  1232  1233  1234  1235  1236  1237  1238  1239  1240  1241  1242  1243  1244  1245  1246  1247  1248  1249  1250  1251  1252  1253  1254  1255  1256  1257  1258  1259  1260  1261  1262  1263  1264  1265  1266  1267  1268  1269  1270  1271  1272  1273  1274  1275  1276  1277  1278  1279  1280  1281  1282  1283  1284  1285  1286  1287  1288  1289  1290  1291  1292 
